Bill
SB 855
AN ACT CONCERNING FUNDING FOR THE PSYCHEDELIC-ASSISTED THERAPY PILOT PROGRAM.
Connecticut bill would fund a pilot program to study psychedelic-assisted therapy as clinical treatment for mental health conditions.
Bill
SB 855
Connecticut bill would fund a pilot program to study psychedelic-assisted therapy as clinical treatment for mental health conditions.
SB 855 would establish funding for a pilot program in Connecticut to study and provide psychedelic-assisted therapy, likely involving substances like psilocybin or MDMA under controlled clinical settings. The bill has been referred to the Joint Committee on Appropriations, indicating it requires dedicated state funding to implement the program.
Psychedelic-assisted therapy represents an emerging treatment approach with preliminary research suggesting potential benefits for treatment-resistant depression, PTSD, and end-of-life anxiety. Connecticut would be among early-adopter states exploring whether these therapies warrant expansion beyond current federal restrictions, positioning the state as a research leader while potentially offering treatment options to residents with limited alternatives.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.